日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Consultation report - considerations for a regulatory pathway for bivalent Salmonella Typhi/Paratyphi A vaccines for use in endemic countries

咨询报告——关于在流行国家使用二价伤寒/甲型副伤寒沙门氏菌疫苗的监管途径的考量

期刊:
影响因子:
doi:10.1016/j.vaccine.2025.127189
Ibarz-Pavon, Ana Belen; Bielsky, Marie-Christine; Bose, Rubina; Cavaleri, Marco; Crump, John A; Hombach, Joachim; Kaslow, David C; Khaman, Farhana; MacLennan, Calman A; Mehring-LeDoare, Kirsty; Pollard, Andrew J; Quadri, Firdausi; John, Jacob; Wilder-Smith, Annelies
发表日期：2025
文献求助 收藏

Realising the potential of correlates of protection for vaccine development, licensure and use: short summary

认识到保护性相关因素在疫苗研发、许可和使用中的潜力：简要概述

期刊:NPJ Vaccines
影响因子:6.5
doi:10.1038/s41541-024-00872-6
King, Deborah F; Groves, Helen; Weller, Charlie; Jones, Ian; Cramer, Jakob P; Gilbert, Peter B; Goldblatt, David; Gruber, Marion F; Kampmann, Beate; Maïga, Diadié; Pasetti, Marcela F; Plotkin, Stanley A; Precioso, Alexander; Wassie, Liya; Wittke, Frederick; Kaslow, David C
发表日期：2024
文献求助 收藏

Fourth Controlled Human Infection Model (CHIM) meeting, CHIM regulatory issues, May 24, 2023

第四届受控人体感染模型（CHIM）会议，CHIM监管问题，2023年5月24日

期刊:Biologicals
影响因子:1.5
doi:10.1016/j.biologicals.2024.101745
Cavaleri, Marco; Kaslow, David; Boateng, Eric; Chen, Wilbur H; Chiu, Christopher; Choy, Robert K M; Correa-Oliveira, Rodrigo; Durbin, Anna; Egesa, Moses; Gibani, Malick; Kapulu, Melissa; Katindi, Melba; Olotu, Ally; Pongsuwan, Pongphaya; Simuyandi, Michelo; Speder, Bruno; Talaat, Kawsar R; Weller, Charlie; Wills, Bridget; Baay, Marc; Balasingam, Shobana; Olesen, Ole F; Neels, Pieter
炎症/感染
Human
发表日期：2024
文献求助 收藏

Clinical and regulatory development strategies for Shigella vaccines intended for children younger than 5 years in low-income and middle-income countries

针对低收入和中等收入国家5岁以下儿童的志贺氏菌疫苗的临床和监管开发策略

期刊:Lancet Global Health
影响因子:18
doi:10.1016/S2214-109X(23)00421-7
Giersing, Birgitte K; Isbrucker, Richard; Kaslow, David C; Cavaleri, Marco; Baylor, Norman; Maiga, Diadié; Pavlinac, Patricia B; Riddle, Mark S; Kang, Gagandeep; MacLennan, Calman A
发表日期：2023
文献求助 收藏

The Full Value of Vaccine Assessments (FVVA): a framework for assessing and communicating the value of vaccines for investment and introduction decision-making

疫苗价值评估（FVVA）：一个用于评估和传达疫苗价值以支持投资和引进决策的框架

期刊:BMC Medicine
影响因子:8.3
doi:10.1186/s12916-023-02929-0
Hutubessy, Raymond; Lauer, Jeremy A; Giersing, Birgitte; Sim, So Yoon; Jit, Mark; Kaslow, David; Botwright, Siobhan
发表日期：2023
文献求助 收藏

Emerging evidence on heterologous COVID-19 vaccine schedules-To mix or not to mix?

关于异源新冠疫苗接种方案的新证据——混合接种还是不混合接种？

期刊:Lancet Infectious Diseases
影响因子:31
doi:10.1016/S1473-3099(22)00178-5
Parker, Edward P K; Desai, Shalini; Marti, Melanie; O'Brien, Katherine L; Kaslow, David C; Kochhar, Sonali; Olayinka, Folake; Cravioto, Alejandro; Nohynek, Hanna; Hombach, Joachim; Wilder-Smith, Annelies
微生物学
新冠
发表日期：2022
文献求助 收藏

Response to additional COVID-19 vaccine doses in people who are immunocompromised: a rapid review

对免疫功能低下人群接种额外剂量新冠疫苗的反应：一项快速综述

期刊:Lancet Global Health
影响因子:18
doi:10.1016/S2214-109X(21)00593-3
Parker, Edward P K; Desai, Shalini; Marti, Melanie; Nohynek, Hanna; Kaslow, David C; Kochhar, Sonali; O'Brien, Katherine L; Hombach, Joachim; Wilder-Smith, Annelies
微生物学
新冠
免疫/内分泌
发表日期：2022
文献求助 收藏

The silent and dangerous inequity around access to COVID-19 testing: A call to action

新冠病毒检测机会方面存在的隐形且危险的不平等：行动呼吁

期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2021.101230
Batista, Carolina; Hotez, Peter; Amor, Yanis Ben; Kim, Jerome H; Kaslow, David; Lall, Bhavna; Ergonul, Onder; Figueroa, J Peter; Gursel, Mayda; Hassanain, Mazen; Kang, Gagandeep; Larson, Heidi; Naniche, Denise; Sheahan, Timothy; Wilder-Smith, Annelies; Shoham, Shmuel; Sow, Samba O; Yadav, Prashant; Strub-Wourgaft, Nathalie; Loveday, Sarah-Jane; Hannay, Emma; Bottazzi, Maria Elena
微生物学
新冠
Virus detection
发表日期：2022
文献求助 收藏

A Systematic Framework for Prioritizing Burden of Disease Data Required for Vaccine Development and Implementation: The Case for Group A Streptococcal Diseases

疫苗研发和实施所需疾病负担数据优先排序的系统框架：以A组链球菌疾病为例

期刊:Clinical Infectious Diseases
影响因子:7.3
doi:10.1093/cid/ciac291
Moore, Hannah C; Cannon, Jeffrey W; Kaslow, David C; Lamagni, Theresa; Bowen, Asha C; Miller, Kate M; Cherian, Thomas; Carapetis, Jonathan; Van Beneden, Chris
发表日期：2022
文献求助 收藏

KSHV (HHV8) vaccine: promises and potential pitfalls for a new anti-cancer vaccine

KSHV（HHV8）疫苗：一种新型抗癌疫苗的希望与潜在缺陷

期刊:NPJ Vaccines
影响因子:6.5
doi:10.1038/s41541-022-00535-4
Casper, Corey; Corey, Lawrence; Cohen, Jeffrey I; Damania, Blossom; Gershon, Anne A; Kaslow, David C; Krug, Laurie T; Martin, Jeffrey; Mbulaiteye, Sam M; Mocarski, Edward S; Moore, Patrick S; Ogembo, Javier Gordon; Phipps, Warren; Whitby, Denise; Wood, Charles
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏